The Road from Intermittently Scanned Glucose Monitoring to Hybrid Closed-loop Systems: Part A. Keys to Success: Subject Profiles, Choice of Systems, Education

Overview

Journal Ther Adv Endocrinol Metab

Specialty Endocrinology

Date 2019 Aug 7

PMID 31384420

Citations 8

Authors

Francesca De Ridder

Marieke den Brinker

Christophe De Block

Affiliations

Soon will be listed here.

Abstract

Managing type 1 diabetes (T1DM) is challenging and requires intensive glucose monitoring and titration of insulin in order to reduce the risk of complications. The use of continuous glucose monitoring (CGM) systems, either flash or intermittently scanned glucose monitoring (isCGM) or real-time (RT) CGM, has positively affected the management of type 1 diabetes with the potential to lower HbA1c, enhance time spent in range, reduce frequency and time spent in hypoglycemia and hyperglycemia, lower glycemic variability, and improve quality of life. In recent years, both CGM and pump technology have advanced, with improved functional features and integration, including low glucose suspend (LGS), predictive low glucose suspend (PLGS), and hybrid closed-loop (HCL) systems. In this review, we highlight the benefits and limitations of use of isCGM/RT-CGM for open-loop control and recent progress in closed-loop control systems. We also discuss different subject profiles for the different systems, and focus on educational aspects that are key to successful use of the systems.

Citing Articles

The Reporting Quality of Machine Learning Studies on Pediatric Diabetes Mellitus: Systematic Review.

Zrubka Z, Kertesz G, Gulacsi L, Czere J, Holgyesi A, Nezhad H J Med Internet Res. 2024; 26:e47430.

PMID: 38241075 PMC: 10837761. DOI: 10.2196/47430.

Impact on glucometric variables and quality of life of the advanced hybrid closed-loop system in pediatric and adolescent type 1 diabetes.

Lendinez-Jurado A, Gomez-Perea A, Ariza-Jimenez A, Tapia-Ceballos L, Becerra-Paz I, Martos-Lirio M J Diabetes. 2023; 15(8):699-708.

PMID: 37337407 PMC: 10415871. DOI: 10.1111/1753-0407.13426.

Insulin pumps in children - a systematic review.

Al-Beltagi M, Saeed N, Bediwy A, Elbeltagi R World J Clin Pediatr. 2022; 11(6):463-484.

PMID: 36439904 PMC: 9685680. DOI: 10.5409/wjcp.v11.i6.463.

A review of flash glucose monitoring in type 2 diabetes.

Krakauer M, Botero J, Lavalle-Gonzalez F, Proietti A, Barbieri D Diabetol Metab Syndr. 2021; 13(1):42.

PMID: 33836819 PMC: 8035716. DOI: 10.1186/s13098-021-00654-3.

Flash Glucose Monitoring and Patient Satisfaction: A Meta-Review of Systematic Reviews.

Diez-Fernandez A, Rodriguez-Huerta M, Miron-Gonzalez R, Laredo-Aguilera J, Martin-Espinosa N Int J Environ Res Public Health. 2021; 18(6).

PMID: 33803558 PMC: 8003041. DOI: 10.3390/ijerph18063123.

References

Tamborlane W, Beck R, Bode B, Buckingham B, Peter Chase H, Clemons R . Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359(14):1464-76. DOI: 10.1056/NEJMoa0805017. View

De Block C, Manuel-y-Keenoy B, Van Gaal L . A review of current evidence with continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol. 2009; 2(4):718-27. PMC: 2769750. DOI: 10.1177/193229680800200426. View

Bergenstal R, Tamborlane W, Ahmann A, Buse J, Dailey G, Davis S . Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010; 363(4):311-20. DOI: 10.1056/NEJMoa1002853. View

Hermanides J, Norgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan C . Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabet Med. 2011; 28(10):1158-67. DOI: 10.1111/j.1464-5491.2011.03256.x. View

Riveline J, Schaepelynck P, Chaillous L, Renard E, Sola-Gazagnes A, Penfornis A . Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study. Diabetes Care. 2012; 35(5):965-71. PMC: 3329830. DOI: 10.2337/dc11-2021. View

Battelino T, Conget I, Olsen B, Schutz-Fuhrmann I, Hommel E, Hoogma R . The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012; 55(12):3155-62. PMC: 3483098. DOI: 10.1007/s00125-012-2708-9. View

Norgaard K, Scaramuzza A, Bratina N, Lalic N, Jarosz-Chobot P, Kocsis G . Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther. 2013; 15(4):273-80. PMC: 3696941. DOI: 10.1089/dia.2012.0288. View

Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S . Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013; 368(9):824-33. DOI: 10.1056/NEJMoa1206881. View

Bergenstal R, Ahmann A, Bailey T, Beck R, Bissen J, Buckingham B . Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol. 2013; 7(2):562-78. PMC: 3737658. DOI: 10.1177/193229681300700234. View

10.

Bergenstal R, Klonoff D, Garg S, Bode B, Meredith M, Slover R . Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013; 369(3):224-32. DOI: 10.1056/NEJMoa1303576. View

11.

Sundberg F, Forsander G . Detection and treatment efficacy of hypoglycemic events in the everyday life of children younger than 7 yr. Pediatr Diabetes. 2013; 15(1):34-40. DOI: 10.1111/pedi.12057. View

12.

Ly T, Nicholas J, Retterath A, Lim E, Davis E, Jones T . Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA. 2013; 310(12):1240-7. DOI: 10.1001/jama.2013.277818. View

13.

Doyle 3rd F, Huyett L, Lee J, Zisser H, Dassau E . Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care. 2014; 37(5):1191-7. PMC: 3994938. DOI: 10.2337/dc13-2108. View

14.

Maahs D, Calhoun P, Buckingham B, Peter Chase H, Hramiak I, Lum J . A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care. 2014; 37(7):1885-91. PMC: 4067393. DOI: 10.2337/dc13-2159. View

15.

Little S, Leelarathna L, Walkinshaw E, Tan H, Chapple O, Lubina-Solomon A . Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring.... Diabetes Care. 2014; 37(8):2114-22. DOI: 10.2337/dc14-0030. View

16.

Wong J, Foster N, Maahs D, Raghinaru D, Bergenstal R, Ahmann A . Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014; 37(10):2702-9. PMC: 4392936. DOI: 10.2337/dc14-0303. View

17.

Kovatchev B, Patek S, Ortiz E, Breton M . Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther. 2014; 17(3):177-86. PMC: 4346608. DOI: 10.1089/dia.2014.0272. View

18.

Kowalski A . Pathway to artificial pancreas systems revisited: moving downstream. Diabetes Care. 2015; 38(6):1036-43. DOI: 10.2337/dc15-0364. View

19.

Thabit H, Tauschmann M, Allen J, Leelarathna L, Hartnell S, Wilinska M . Home Use of an Artificial Beta Cell in Type 1 Diabetes. N Engl J Med. 2015; 373(22):2129-2140. PMC: 4697362. DOI: 10.1056/NEJMoa1509351. View

20.

Kropff J, Del Favero S, Place J, Toffanin C, Visentin R, Monaro M . 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. Lancet Diabetes Endocrinol. 2015; 3(12):939-47. DOI: 10.1016/S2213-8587(15)00335-6. View